CVS HEALTH CORPORATION Proceeds from Sale of Debt Securities, Available-for-sale
CVS HEALTH CORPORATION (CVS) reported Proceeds from Sale of Debt Securities, Available-for-sale of $1.94 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt · last filed 2026-08-05
- CVS HEALTH CORPORATION proceeds from sale of debt securities, available-for-sale for the quarter ending 2026-06-30 was $1.94B, a 25.92% decline year-over-year.
- CVS HEALTH CORPORATION proceeds from sale of debt securities, available-for-sale for the quarter ending 2026-03-31 was $2.95B, a 35.01% increase year-over-year.
- CVS HEALTH CORPORATION proceeds from sale of debt securities, available-for-sale for the quarter ending 2025-12-31 was $1.94B, a 51.09% increase year-over-year.
- CVS HEALTH CORPORATION proceeds from sale of debt securities, available-for-sale for the quarter ending 2025-09-30 was $1.84B, a 20.93% decline year-over-year.
- CVS HEALTH CORPORATION proceeds from sale of debt securities, available-for-sale for fiscal 2025 was $8.59B, a 32.33% increase from fiscal 2024.
- CVS HEALTH CORPORATION proceeds from sale of debt securities, available-for-sale for fiscal 2024 was $6.49B, a 28.98% increase from fiscal 2023.
- CVS HEALTH CORPORATION proceeds from sale of debt securities, available-for-sale for fiscal 2023 was $5.03B, a 18.57% increase from fiscal 2022.
- CVS HEALTH CORPORATION proceeds from sale of debt securities, available-for-sale for fiscal 2022 was $4.24B, a 18.78% increase from fiscal 2021.
| Period end | Proceeds from Sale of Debt Securities, Available-for-sale 3 month | Proceeds from Sale of Debt Securities, Available-for-sale 6 month | Proceeds from Sale of Debt Securities, Available-for-sale 9 month | Proceeds from Sale of Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.94B 10-Q · filed 2026-08-05 | $4.89B 10-Q · filed 2026-08-05 | $6.84B derived: sum of 3 quarters · filed 2026-08-05 | $8.67B derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $2.95B 10-Q · filed 2026-05-06 | $4.89B derived: sum of 2 quarters · filed 2026-05-06 | $6.73B derived: sum of 3 quarters · filed 2026-05-06 | $9.35B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.94B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $3.78B derived: sum of 2 quarters · filed 2026-02-10 | $6.40B derived: sum of 3 quarters · filed 2026-08-05 | $8.59B 10-K · filed 2026-02-10 |
| 2025-09-30 | $1.84B 10-Q · filed 2025-10-29 | $4.46B derived: sum of 2 quarters · filed 2026-08-05 | $6.64B 10-Q · filed 2025-10-29 | $7.93B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $2.62B 10-Q · filed 2026-08-05 | $4.81B 10-Q · filed 2026-08-05 | $6.09B derived: sum of 3 quarters · filed 2026-08-05 | $8.42B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $2.19B 10-Q · filed 2026-05-06 | $3.47B derived: sum of 2 quarters · filed 2026-05-06 | $5.79B derived: sum of 3 quarters · filed 2026-05-06 | $7.41B derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $1.29B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $3.61B derived: sum of 2 quarters · filed 2026-02-10 | $5.22B derived: sum of 3 quarters · filed 2026-02-10 | $6.49B 10-K · filed 2026-02-10 |
| 2024-09-30 | $2.32B 10-Q · filed 2025-10-29 | $3.94B derived: sum of 2 quarters · filed 2025-10-29 | $5.20B 10-Q · filed 2025-10-29 | $6.73B derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | $1.62B 10-Q · filed 2025-07-31 | $2.88B 10-Q · filed 2025-07-31 | $4.41B derived: sum of 3 quarters · filed 2026-02-10 | $5.58B derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $1.26B 10-Q · filed 2025-05-01 | $2.79B derived: sum of 2 quarters · filed 2026-02-10 | $3.96B derived: sum of 3 quarters · filed 2026-02-10 | $4.96B derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $1.53B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $2.70B derived: sum of 2 quarters · filed 2026-02-10 | $3.69B derived: sum of 3 quarters · filed 2026-02-10 | $5.03B 10-K · filed 2026-02-10 |
| 2023-09-30 | $1.17B 10-Q · filed 2024-11-06 | $2.16B derived: sum of 2 quarters · filed 2024-11-06 | $3.50B 10-Q · filed 2024-11-06 | $4.19B derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | $991.00M 10-Q · filed 2024-08-07 | $2.33B 10-Q · filed 2024-08-07 | $3.02B derived: sum of 3 quarters · filed 2025-02-12 | $3.61B derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | $1.34B 10-Q · filed 2024-05-01 | $2.03B derived: sum of 2 quarters · filed 2025-02-12 | $2.62B derived: sum of 3 quarters · filed 2025-02-12 | $3.67B derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | $687.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $1.28B derived: sum of 2 quarters · filed 2025-02-12 | $2.33B derived: sum of 3 quarters · filed 2025-02-12 | $4.24B 10-K · filed 2025-02-12 |
| 2022-09-30 | $593.00M 10-Q · filed 2023-11-01 | $1.65B derived: sum of 2 quarters · filed 2023-11-01 | $3.56B 10-Q · filed 2023-11-01 | $4.19B derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-06-30 | $1.05B 10-Q · filed 2023-08-02 | $2.96B 10-Q · filed 2023-08-02 | $3.60B derived: sum of 3 quarters · filed 2024-02-07 | $4.27B derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-03-31 | $1.91B 10-Q · filed 2023-05-03 | $2.55B derived: sum of 2 quarters · filed 2024-02-07 | $3.22B derived: sum of 3 quarters · filed 2024-02-07 | $4.13B derived: sum of 4 quarters · filed 2024-02-07 |
| 2021-12-31 | $637.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $1.30B derived: sum of 2 quarters · filed 2024-02-07 | $2.22B derived: sum of 3 quarters · filed 2024-02-07 | $3.57B 10-K · filed 2024-02-07 |
| 2021-09-30 | $668.00M 10-Q · filed 2022-11-02 | $1.59B derived: sum of 2 quarters · filed 2022-11-02 | $2.94B 10-Q · filed 2022-11-02 | $4.52B derived: sum of 4 quarters · filed 2023-05-25 |
| 2021-06-30 | $919.00M 10-Q · filed 2022-08-03 | $2.27B 10-Q · filed 2022-08-03 | $3.86B derived: sum of 3 quarters · filed 2023-05-25 | $4.76B derived: sum of 4 quarters · filed 2023-05-25 |
| 2021-03-31 | $1.35B 10-Q · filed 2022-05-04 | $2.94B derived: sum of 2 quarters · filed 2023-05-25 | $3.84B derived: sum of 3 quarters · filed 2023-05-25 | $5.26B derived: sum of 4 quarters · filed 2023-05-25 |
| 2020-12-31 | $1.59B derived: 8-K 12 month − 10-Q 9 month · filed 2023-05-25 | $2.49B derived: sum of 2 quarters · filed 2023-05-25 | $3.91B derived: sum of 3 quarters · filed 2023-05-25 | $3.91B 8-K · filed 2023-05-25 |
| 2020-09-30 | $905.00M 10-Q · filed 2021-11-03 | $2.32B derived: sum of 2 quarters · filed 2021-11-03 | $2.32B 10-Q · filed 2021-11-03 | $3.73B derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-06-30 | $1.42B 10-Q · filed 2021-08-04 | $2.14B 10-Q · filed 2021-08-04 | $2.83B derived: sum of 3 quarters · filed 2022-02-09 | $4.15B derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-03-31 | $723.00M 10-Q · filed 2021-05-04 | $1.41B derived: sum of 2 quarters · filed 2022-02-09 | $2.73B derived: sum of 3 quarters · filed 2022-02-09 | $4.01B derived: sum of 4 quarters · filed 2022-02-09 |
| 2019-12-31 | $686.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $2.01B derived: sum of 2 quarters · filed 2022-02-09 | $3.28B derived: sum of 3 quarters · filed 2022-02-09 | $4.77B 10-K · filed 2022-02-09 |
| 2019-09-30 | $1.32B 10-Q · filed 2020-11-06 | $2.60B derived: sum of 2 quarters · filed 2020-11-06 | $4.09B 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $1.27B 10-Q · filed 2020-08-05 | $2.76B 10-Q · filed 2020-08-05 | ||
| 2019-03-31 | $1.49B 10-Q · filed 2020-05-06 | |||
| 2018-12-31 | $389.00M 10-K · filed 2021-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |